Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial

Abstract Background Canada has one of the highest rates of multiple sclerosis (MS) in the world. Treatments and supports for people with MS (PwMS) have become increasingly complex, requiring individualized and adaptive care. Specialized NPs provide advanced skills to those with complex medical condi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Penelope Smyth, Kaitlyn E. Watson, Ross T. Tsuyuki
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/69d049650f3f4ed9986fee7bd768e853
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:69d049650f3f4ed9986fee7bd768e853
record_format dspace
spelling oai:doaj.org-article:69d049650f3f4ed9986fee7bd768e8532021-11-14T12:31:02ZMeasuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial10.1186/s13063-021-05726-31745-6215https://doaj.org/article/69d049650f3f4ed9986fee7bd768e8532021-11-01T00:00:00Zhttps://doi.org/10.1186/s13063-021-05726-3https://doaj.org/toc/1745-6215Abstract Background Canada has one of the highest rates of multiple sclerosis (MS) in the world. Treatments and supports for people with MS (PwMS) have become increasingly complex, requiring individualized and adaptive care. Specialized NPs provide advanced skills to those with complex medical conditions, with potential to enhance the health, functioning, and quality of life for PwMS. This study aims to determine the effect of a Nurse Practitioner (NP) on depression and anxiety levels in PwMS. Methods We will perform a parallel randomized controlled trial. PwMS who are followed by general private-practice neurologists will be randomly assigned to the intervention group (NP-led care) or the ‘usual care’ control group (general neurologist or family physician and registered nurse support). In the intervention group, the NP will assess and provide care to the MS patient and their caregiver at a baseline visit, with 3-month and 6-month follow-up visits. PwMS in the control group will receive usual care provided by their community neurologists or family physicians with the standard assistance provided by registered nurses experienced in MS care. The primary outcome will be the difference in change in the patient’s anxiety and depression scores as measured by the validated Hospital Anxiety and Depression Scale (HADS) questionnaire at 3 months. Secondary outcomes will include difference in change in HADS at 6 months; Modified Fatigue Impact Scale scores (MSIF) at 3 and 6 months; EQ-5D scores at 3 and 6 months; caregiver health-related quality of life in MS measures (CAREQOL-MS) at 3 and 6 months; number of visits and phone calls to healthcare professionals recorded by patient, and satisfaction with NP-led care vs usual care measured by the validated Consultant Satisfaction Questionnaire. Discussion Findings from this study will contribute to exploring benefits of advanced nursing practitioner interventions for PwMS followed by general neurologists and family physicians in a community setting. It will provide evidence of the benefits of NP-led care for PwMS and offer an alternative healthcare resource for management of MS. Trial registration ClinicalTrials.gov Pro00069595 . Retrospectively registered on June 26, 2020. Protocol version: January 2017, version 1.Penelope SmythKaitlyn E. WatsonRoss T. TsuyukiBMCarticleMultiple sclerosisDepressionAnxietyNurse practitionerPatient satisfactionHealthcare deliveryMedicine (General)R5-920ENTrials, Vol 22, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Multiple sclerosis
Depression
Anxiety
Nurse practitioner
Patient satisfaction
Healthcare delivery
Medicine (General)
R5-920
spellingShingle Multiple sclerosis
Depression
Anxiety
Nurse practitioner
Patient satisfaction
Healthcare delivery
Medicine (General)
R5-920
Penelope Smyth
Kaitlyn E. Watson
Ross T. Tsuyuki
Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial
description Abstract Background Canada has one of the highest rates of multiple sclerosis (MS) in the world. Treatments and supports for people with MS (PwMS) have become increasingly complex, requiring individualized and adaptive care. Specialized NPs provide advanced skills to those with complex medical conditions, with potential to enhance the health, functioning, and quality of life for PwMS. This study aims to determine the effect of a Nurse Practitioner (NP) on depression and anxiety levels in PwMS. Methods We will perform a parallel randomized controlled trial. PwMS who are followed by general private-practice neurologists will be randomly assigned to the intervention group (NP-led care) or the ‘usual care’ control group (general neurologist or family physician and registered nurse support). In the intervention group, the NP will assess and provide care to the MS patient and their caregiver at a baseline visit, with 3-month and 6-month follow-up visits. PwMS in the control group will receive usual care provided by their community neurologists or family physicians with the standard assistance provided by registered nurses experienced in MS care. The primary outcome will be the difference in change in the patient’s anxiety and depression scores as measured by the validated Hospital Anxiety and Depression Scale (HADS) questionnaire at 3 months. Secondary outcomes will include difference in change in HADS at 6 months; Modified Fatigue Impact Scale scores (MSIF) at 3 and 6 months; EQ-5D scores at 3 and 6 months; caregiver health-related quality of life in MS measures (CAREQOL-MS) at 3 and 6 months; number of visits and phone calls to healthcare professionals recorded by patient, and satisfaction with NP-led care vs usual care measured by the validated Consultant Satisfaction Questionnaire. Discussion Findings from this study will contribute to exploring benefits of advanced nursing practitioner interventions for PwMS followed by general neurologists and family physicians in a community setting. It will provide evidence of the benefits of NP-led care for PwMS and offer an alternative healthcare resource for management of MS. Trial registration ClinicalTrials.gov Pro00069595 . Retrospectively registered on June 26, 2020. Protocol version: January 2017, version 1.
format article
author Penelope Smyth
Kaitlyn E. Watson
Ross T. Tsuyuki
author_facet Penelope Smyth
Kaitlyn E. Watson
Ross T. Tsuyuki
author_sort Penelope Smyth
title Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial
title_short Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial
title_full Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial
title_fullStr Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial
title_full_unstemmed Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial
title_sort measuring the effects of nurse practitioner (np)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial
publisher BMC
publishDate 2021
url https://doaj.org/article/69d049650f3f4ed9986fee7bd768e853
work_keys_str_mv AT penelopesmyth measuringtheeffectsofnursepractitionernpledcareondepressionandanxietylevelsinpeoplewithmultiplesclerosisastudyprotocolforarandomizedcontrolledtrial
AT kaitlynewatson measuringtheeffectsofnursepractitionernpledcareondepressionandanxietylevelsinpeoplewithmultiplesclerosisastudyprotocolforarandomizedcontrolledtrial
AT rossttsuyuki measuringtheeffectsofnursepractitionernpledcareondepressionandanxietylevelsinpeoplewithmultiplesclerosisastudyprotocolforarandomizedcontrolledtrial
_version_ 1718429172347437056